RO.CH

300.8

+0.8%↑

NOVN.CH

105.4

+1.27%↑

LONN.CH

549.8

+1.4%↑

SDZ.CH

46.38

+1.49%↑

STMN.CH

88.72

+0.91%↑

RO.CH

300.8

+0.8%↑

NOVN.CH

105.4

+1.27%↑

LONN.CH

549.8

+1.4%↑

SDZ.CH

46.38

+1.49%↑

STMN.CH

88.72

+0.91%↑

RO.CH

300.8

+0.8%↑

NOVN.CH

105.4

+1.27%↑

LONN.CH

549.8

+1.4%↑

SDZ.CH

46.38

+1.49%↑

STMN.CH

88.72

+0.91%↑

RO.CH

300.8

+0.8%↑

NOVN.CH

105.4

+1.27%↑

LONN.CH

549.8

+1.4%↑

SDZ.CH

46.38

+1.49%↑

STMN.CH

88.72

+0.91%↑

RO.CH

300.8

+0.8%↑

NOVN.CH

105.4

+1.27%↑

LONN.CH

549.8

+1.4%↑

SDZ.CH

46.38

+1.49%↑

STMN.CH

88.72

+0.91%↑

Search

Sonova Holding AG

Gesloten

SectorGezondheidszorg

219.4 0.27

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

216.3

Max

220.7

Belangrijke statistieken

By Trading Economics

Inkomsten

443M

Verkoop

2B

K/W

Sectorgemiddelde

24.42

35.739

EPS

5.55

Dividendrendement

1.99

Winstmarge

21.819

Werknemers

18,335

EBITDA

510M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+12.52% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.99%

3.08%

Volgende Winsten

14 nov 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-4.8B

13B

Vorige openingsprijs

219.13

Vorige sluitingsprijs

219.4

Nieuwssentiment

By Acuity

29%

71%

74 / 371 Rangschikking in Healthcare

Sonova Holding AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

25 sep 2025, 13:05 UTC

Belangrijke Marktbewegers

European Med-Tech Stocks Fall After U.S. Opens Import Probe

Peer Vergelijking

Prijswijziging

Sonova Holding AG Prognose

Koersdoel

By TipRanks

12.52% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 243.5 CHF  12.52%

Hoogste 294 CHF

Laagste 195 CHF

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor Sonova Holding AG - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

8 ratings

2

Buy

3

Hold

3

Sell

Sentiment

By Acuity

74 / 371 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Sonova Holding AG

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. The company was founded in 1947 and is headquartered in Stäfa, Switzerland.
help-icon Live chat